390 related articles for article (PubMed ID: 22237706)
1. Predictive pathology in routine diagnostics of solid tumors.
Lassmann S; Werner M
Histol Histopathol; 2012 Mar; 27(3):289-96. PubMed ID: 22237706
[TBL] [Abstract][Full Text] [Related]
2. A 2015 update on predictive molecular pathology and its role in targeted cancer therapy: a review focussing on clinical relevance.
Dietel M; Jöhrens K; Laffert MV; Hummel M; Bläker H; Pfitzner BM; Lehmann A; Denkert C; Darb-Esfahani S; Lenze D; Heppner FL; Koch A; Sers C; Klauschen F; Anagnostopoulos I
Cancer Gene Ther; 2015 Sep; 22(9):417-30. PubMed ID: 26358176
[TBL] [Abstract][Full Text] [Related]
3. Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial.
Le Tourneau C; Delord JP; Gonçalves A; Gavoille C; Dubot C; Isambert N; Campone M; Trédan O; Massiani MA; Mauborgne C; Armanet S; Servant N; Bièche I; Bernard V; Gentien D; Jezequel P; Attignon V; Boyault S; Vincent-Salomon A; Servois V; Sablin MP; Kamal M; Paoletti X;
Lancet Oncol; 2015 Oct; 16(13):1324-34. PubMed ID: 26342236
[TBL] [Abstract][Full Text] [Related]
4. Morphological control for molecular testing: a practical approach.
Gullo I; Marques A; Pinto R; Cirnes L; Schmitt F
J Clin Pathol; 2021 May; 74(5):331-333. PubMed ID: 32763918
[TBL] [Abstract][Full Text] [Related]
5. Study protocol: Whole genome sequencing Implementation in standard Diagnostics for Every cancer patient (WIDE).
Samsom KG; Bosch LJW; Schipper LJ; Roepman P; de Bruijn E; Hoes LR; Riethorst I; Schoenmaker L; van der Kolk LE; Retèl VP; Frederix GWJ; Buffart TE; van der Hoeven JJM; Voest EE; Cuppen E; Monkhorst K; Meijer GA
BMC Med Genomics; 2020 Nov; 13(1):169. PubMed ID: 33167975
[TBL] [Abstract][Full Text] [Related]
6. Implementation of a Precision Pathology Program Focused on Oncology-Based Prognostic and Predictive Outcomes.
Donovan MJ; Cordon-Cardo C
Mol Diagn Ther; 2017 Apr; 21(2):115-123. PubMed ID: 28000172
[TBL] [Abstract][Full Text] [Related]
7. Drug sensitivity testing platforms for gastric cancer diagnostics.
Lau V; Wong AL; Ng C; Mok Y; Lakshmanan M; Yan B
J Clin Pathol; 2016 Feb; 69(2):93-6. PubMed ID: 26567318
[TBL] [Abstract][Full Text] [Related]
8. Multisite tumor sampling: a new tumor selection method to enhance intratumor heterogeneity detection.
López JI; Cortés JM
Hum Pathol; 2017 Jun; 64():1-6. PubMed ID: 28237785
[TBL] [Abstract][Full Text] [Related]
9. Molecular Pathology: A Requirement for Precision Medicine in Cancer.
Dietel M
Oncol Res Treat; 2016; 39(12):804-810. PubMed ID: 27889782
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemistry 2015: Protein correlates of molecular alterations and predictive testing.
Hornick JL
Semin Diagn Pathol; 2015 Sep; 32(5):323-4. PubMed ID: 26250936
[No Abstract] [Full Text] [Related]
11. Cancer diagnostics: The journey from histomorphology to molecular profiling.
Ahmed AA; Abedalthagafi M
Oncotarget; 2016 Sep; 7(36):58696-58708. PubMed ID: 27509178
[TBL] [Abstract][Full Text] [Related]
12. Whole-Exome Sequencing of Metastatic Cancer and Biomarkers of Treatment Response.
Beltran H; Eng K; Mosquera JM; Sigaras A; Romanel A; Rennert H; Kossai M; Pauli C; Faltas B; Fontugne J; Park K; Banfelder J; Prandi D; Madhukar N; Zhang T; Padilla J; Greco N; McNary TJ; Herrscher E; Wilkes D; MacDonald TY; Xue H; Vacic V; Emde AK; Oschwald D; Tan AY; Chen Z; Collins C; Gleave ME; Wang Y; Chakravarty D; Schiffman M; Kim R; Campagne F; Robinson BD; Nanus DM; Tagawa ST; Xiang JZ; Smogorzewska A; Demichelis F; Rickman DS; Sboner A; Elemento O; Rubin MA
JAMA Oncol; 2015 Jul; 1(4):466-74. PubMed ID: 26181256
[TBL] [Abstract][Full Text] [Related]
13. How Imaging Biomarkers Can Inform Clinical Trials and Clinical Practice in the Era of Targeted Cancer Therapy.
Farwell MD; Clark AS; Mankoff DA
JAMA Oncol; 2015 Jul; 1(4):421-2. PubMed ID: 26181243
[No Abstract] [Full Text] [Related]
14. [Molecular Pathology Diagnosis as Companion Diagnostics].
Fujii S
Gan To Kagaku Ryoho; 2024 Apr; 51(4):383-387. PubMed ID: 38644301
[TBL] [Abstract][Full Text] [Related]
15. Precision oncology: where next?
Gore M; Larkin J
Lancet Oncol; 2015 Dec; 16(16):1593-5. PubMed ID: 26678189
[No Abstract] [Full Text] [Related]
16. Fantastic voyage: the future of cancer diagnostics.
Sundaresan TK; Haber DA
Lancet Oncol; 2015 Dec; 16(16):1596-8. PubMed ID: 26678190
[No Abstract] [Full Text] [Related]
17. [Chances and risks of blood-based molecular pathological analysis of circulating tumor cells (CTC) and cell-free DNA (cfDNA) in personalized cancer therapy: positional paper from the study group on liquid biopsy of the working group for molecular pathology in the German Society of Pathology (DGP)].
Dahl E; Jung A; Fassunke J; Hummel M; Penzel R; Dietmaier W; Laßmann S
Pathologe; 2015 Feb; 36(1):92-7. PubMed ID: 25533324
[No Abstract] [Full Text] [Related]
18. Brave-ish New World--What's Needed to Make Precision Oncology a Practical Reality.
MacConaill LE; Lindeman NI; Rollins BJ
JAMA Oncol; 2015 Oct; 1(7):879-80. PubMed ID: 26181886
[No Abstract] [Full Text] [Related]
19. [Predictive biomarkers for tumor-relevant signaling pathways in molecular pathology].
Bonzheim I; Fend F
Pathologe; 2014 Feb; 35(1):93-105. PubMed ID: 24496994
[TBL] [Abstract][Full Text] [Related]
20. Triple-negative Breast Carcinoma: Morphologic and Molecular Subtypes.
Bose S
Adv Anat Pathol; 2015 Sep; 22(5):306-13. PubMed ID: 26262513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
